Ficus deltoidea: A Potential Alternative Medicine for Diabetes Mellitus

Table 2

Effect of F. deltoidea extracts and rosiglitazone maleate on 3T3F442A adipocyte viability.

F. deltoidea extracts	Cell viability (%)
	Control	10 μg/mL	50 μg/mL	100 μg/mL	500 μg/mL	1000 μg/mL
Hot aqueous	100.00±9.42	90.75±14.33 **; (9.25%)	70.59±4.23 ***; (29.41%)	66.25±2.52 ***; (33.75%)	55.26±3.51 ***; (44.74%)	55.03±1.51 ***; (44.97%)
Ethanolic	100.00±1.10	86.92±3.14 ***; (13.08%)	72.93±1.34 ***; (27.07%)	69.60±1.56 ***; (30.40%)	51.06±0.60 ***; (48.94%)	55.07±6.14 ***; (44.93%)
Methanolic	100.00±1.10	88.65±3.42 ***; (11.35%)	72.54±1.45 ***; (27.46%)	70.99±1.65 ***; (29.01%)	62.61±4.01 ***; (37.39%)	51.55±1.00 ***; (48.45%)
	Control	3.5 μM	7 μM	35 μM	70 μM	140 μM
Rosiglitazone maleate	100.00±7.05	91.57±6.58	77.10±7.31 ***; (22.90%)	71.97±6.53 ***; (28.03%)	54.01±7.41 ***; (45.99%)	49.51±5.74 ***; (50.49%)

Notes: Cells were incubated for 72 hours in the presence of various concentrations of F. deltoidea extracts (10–1000 μg/mL) and rosiglitazone maleate (3.5–140 μM). Values expressed as percentage of means ± standard deviations (𝑛=8) of the cells viability from three independent assays. **𝑃<0.01; ***𝑃<0.001 compared with control. Values between brackets indicate percentage of cell viability reduction.